Live Breaking News & Updates on Suzhou Likang Investment

Stay updated with breaking news from Suzhou likang investment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures


Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures
Source:
Jan Antonin Kolar/Unsplash
May 12, 2021
Biopharmaceutical firm Hangzhou DAC Biotech Co., Ltd has announced the completion of a 1 billion yuan ($156 million) Series C round co-led by PE firm Hillhouse Capital’s venture unit GL Ventures.
State-backed CITIC Private Equity Funds Management (CPE), and CDG Capital a Hong Kong-based investment firm that has invested in healthcare startups like Innovent, Akeso, and Grail were the co-lead investors, DAC Biotech said in a WeChat post on May 8. 
It also attracted new investors including CITIC Securities, healthcare-focussed TigerYeah Capital, and K.Wah Group. ....

Jin Yi , Junshi Biosciences , K Wah Group , Biotech Co Ltd , Fudan University Shanghai Cancer Center , Betta Pharmaceuticals , Hillhouse Capital , Private Equity Funds Management , Hong Kong Based , Tigeryeah Capital , Shanghai Pulmonary Hospital , Beijing Cancer Hospital , Fudan University Shanghai Cancer , Huaihai Pharmaceutical , Bondshine Capital , Jinyi Investment , Addor Capital , Kefa Capital , Heda Capital , Kelun Biotech , Lilly Asia Ventures , Suzhou Likang Investment , Zhuhai Liangheng Investment , ஜின் இ , கே வா குழு , பயோடெக் இணை லிமிடெட் ,

China's Kelun Biotech nets over $77m funding led by CMC-SDIC Capital


streetAsia s premium
subscription service
Unlock your competitive advantage in a
rapidly evolving landscape. Our packages
come with exclusive access to archive
content, data, discount on summit tickets & more.
Be a part of our growing community now.
SUBSCRIBE NOW
Singapore Reporter/s
In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We ....

Kelun Biotech , Shenzhen Listed Kelun Pharmaceutical , China Merchants Capital , Hillhouse Capital , Lilly Asia Ventures , Suzhou Likang Investment , Zhuhai Liangheng , Kelun Pharmaceutical , Southeast China , சீனா வணிகர்கள் மூலதனம் , ஹில்ஹவுஸ் மூலதனம் , லில்லி ஆசியா முயற்சிகள் , தென்கிழக்கு சீனா ,